Etomoxir
Etomoxir is a drug that was primarily developed for the treatment of heart failure. It acts by irreversibly inhibiting carnitine palmitoyltransferase-1 (CPT-1) on the outer mitochondrial membrane, thereby preventing long-chain fatty acids from entering the mitochondria and being metabolized. This forces the cells to switch to glucose oxidation, which is thought to be more efficient.
Mechanism of action
Etomoxir works by inhibiting the enzyme carnitine palmitoyltransferase-1 (CPT-1), which is located on the outer mitochondrial membrane. This enzyme is responsible for the transport of long-chain fatty acids into the mitochondria, where they are oxidized to produce energy. By inhibiting CPT-1, etomoxir prevents the oxidation of fatty acids, forcing the cells to switch to glucose oxidation.
Clinical use
Etomoxir was initially developed for the treatment of heart failure. The rationale behind this was that the heart in heart failure patients tends to rely more on fatty acid oxidation for energy production, which is less efficient than glucose oxidation. By forcing the heart to switch to glucose oxidation, it was hoped that etomoxir could improve heart function.
However, clinical trials with etomoxir have shown mixed results. Some studies have shown improvements in heart function, while others have shown no benefit or even harm. As a result, etomoxir is not currently approved for the treatment of heart failure.
Side effects
The most common side effects of etomoxir include nausea, vomiting, and abdominal pain. In some cases, etomoxir can also cause liver damage.
Research
Research is ongoing into the potential use of etomoxir in other conditions, such as cancer, diabetes, and neurodegenerative diseases. In these conditions, the metabolic switch induced by etomoxir could potentially have therapeutic benefits.
See also
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD